// App-Quantinova.ai

: Influence of Conditioning Regimen Intensity on Outcomes Post-Allogeneic Transplantation for AML in Complete Morphological Remission

Researchers

Presenter

  • Tommy Alfaro

Principal Investigators

  • Fotios V. Michelis

  • Jonas Mattsson

  • Ivan Pasic

  • Mats Remberger

  • Auro Viswabandya

  • Dennis D.H. Kim

  • Igor Novitzky-Basso

  • Rajat Kumar

  • Jeffrey H. Lipton

  • Wilson Lam

  • Arjun D. Law

  • Armin Gerbitz

Medical Centers

  • Princess Margaret Cancer Centre - University Health Network, Toronto, Canada

  • Karolinska Institutet, Uppsala, Sweden

  • Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada

  • Hans Messner Allogeneic Blood and Marrow Transplant Unit, Princess Margaret Cancer Centre, Toronto, Canada

Locations

  • Canada

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Oncology (ONC)

Disease

  • Solid malignancies

  • Graft-versus-host disease

Biomarkers

  • Soluble Complement 5b-9

Drug/Treatment

  • fludarabine tablet

  • Busulfan

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved